Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J. 2005;24:S25–34.
Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J. 2005;24:S104–8.
Edwards KM, Decker MD, Mortimer EA. Pertussis vaccine. In: Plotkin SA, Orenstein WA, eds. Textbook of vaccine. Philadelphia: Saunders; 1999. pp. 293–344.
Cherry JD, Heininger U. Pertussis and other Bordetella infections. In: Feigin C, Demmeler K, eds. Textbook of pediatric infectious diseases. 5th ed. Philadelphia: Saunders; 1588. pp. 1608–2004.
Broutin H, Rohani P, Guégan JF, Grenfell BT, Simondon F. Loss of immunity to pertussis in a rural community in Senegal. Vaccine. 2004;22:594–6.
Olin P, Gustafsson L, Barreto L, et al. Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine. 2003;21:2015–21.
Greenberg DP. Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents. Pediatr Infect Dis J. 2005;24:721–8.
American Academy of Pediatrics. Pertussis. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red book: 2006 report of the committee on infectious diseases. 27th ed. Elk Grove Village: American Academy of Pediatrics; 2006. pp. 498–520.
Expanded programme on immunization, Global Advisory Group. Weekly Epidemiology Record. 1981;56:9–16
Esteghamati MR, Mansour-ghanei R. Guidelines for surveillance of Pertussis (pamphelet). Tehran: Centers for Diseases Control and Prevention. Deputy of Health: Ministry of health and Medical Education; 2009.
Goya MM. pertussis reemergence Notification, Tehran: Centers for Diseases Control and Prevention. Deputy of Health: Ministry of health and Medical Education; No:24740;20 February 2007.
Saffar MJ, Ajami A, Khalilian AR, Qaheri A, Saffar H. Pertussis seroimmunity among mother-infant pairs and infant immune response to pertussis vaccination. Indian Pediatr. 2007;44:916–8.
Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1–65 y. J Infect Dis. 1996;173:1256–9.
Konda T, Kamachi K, Iwaki M, et al. Distribution of pertussis antibodies among different age groups in Japan. Vaccine. 2002;20:1711–7.
García-Corbeira P, Dal-Ré R, Aguilar L, García-de-Lomas J. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study. Vaccine. 2000;18:2173–6.
Baker JD, Halperin SA, Edwards KM, Miller B, Decker M, Stephens D. Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines. J Pediatr. 1992;121:523–7.
Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24:S58–61.
Thomas MG, Ashworth LA, Miller E, Lambert HP. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine. J Infect Dis. 1989;160:838–45.
de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol. 2000;38:800–6.
Eidlitz-Markus T, Mimouni M, Zeharia A. Pertussis symptoms in adolescents and children versus infants: the influence of vaccination and age. Clin Pediatr (Phila). 2007;46:718–23.
Yaari E, Yafe-Zimerman Y, Schwartz SB, et al. Clinical manifestations of Bordetella pertussis infection in immunized children and young adults. Chest. 1999;115:1254–8.
Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis. 1999;28:S112–7.